The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study
Open accessAbstract
Introduction: The trends in prevalence and incidence of Alzheimer's disease (AD) dementia remain uncertain. Methods: A sample of 2794 participants with a clinical diagnosis for AD dementia were included. Results: The 2010 census standardized prevalence of AD dementia was 14.5% (95% CI = 13.7–15.3), and annual incidence was 2.3% (1.7–2.9). Both prevalence and incidence showed substantial variation over time, but no secular trends. The prevalence of AD dementia did not change significantly from 14.6% (95% CI = 13.0, 16.2) in 1994–1997 to 14.7% (95% CI = 13.2, 16.2) in 2010–2012 (P = .84). The annual incidence of AD dementia was 2.8% (95% CI = 2.2, 3.2) in 1998–2000 and 2.2% (95% CI = 1.6, 2.8) in 2004–2006 (P = .20) and remained steady in 2010–2012. The prevalence and incidence among African Americans were approximately twice than those among European Americans. Conclusions: The prevalence and incidence of AD dementia showed substantial variation between 1994 and 2012, but no secular trend.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“in 2011 the average annual incidence in people age 65 to 74 was 0.4% (meaning four of every 1,000 people age 65 to 74 developed Alzheimer's dementia in 2011); in people age 75 to 84, the annual incidence was 3.2% (32 of every 1,000 people); and in people age 85 and older, the incidence was 7.6% (76 of every 1,000 people).259”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [259]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“approximately 910,000 people age 65 or older developed Alzheimer's dementia in the United States in 2011, a number that would be expected to be even higher in 2023 if CHAP estimates were available for that year.259”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [259]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most other prevalence studies also indicate that Black older adults are about twice as likely to have Alzheimer's or other dementias as White older adults.”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [259]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“According to estimates using data from the CHAP study and the U.S. Census Bureau, approximately 910,000 people age 65 or older developed Alzheimer's dementia in the U.S. in 2011, a number that would be expected to be even higher in 2024 if CHAP estimates were available for that year.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [284]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The rate at which new cases of Alzheimer's develop increases dramatically with age: according to estimates from CHAP, in 2011 the average annual incidence in people age 65 to 74 was 0.4% (meaning four of every 1,000 people age 65 to 74 developed Alzheimer's dementia in 2011); in people age 75 to 84, the annual incidence was 3.2% (32 of every 1,000 people); and in people age 85 and older, the incid”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [284]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In line with these observations, most other prevalence studies indicate that Black older adults are about twice as likely to have Alzheimer's or other dementias as White older adults.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [284]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941
Alzheimer disease in the United States (2010–2050) estimated using the 2010 census
Hebert, L. E., Weuve, J., Scherr, P. A., & Evans, D. A. (2013) · Neurology · doi:10.1212/wnl.0b013e31828726f5 · Cited by 2,642
Self-citationAnalysis of Complex Survey Samples
Lumley, T. (2004) · Journal of Statistical Software · doi:10.18637/jss.v009.i08 · Cited by 2,425
Matthews, F. E., Arthur, A., Barnes, L. E., Bond, J., Jagger, C., Robinson, L., & Brayne, C. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61570-6 · Cited by 1,155
Self-citationIncidence of dementia over three decades in the Framingham heart study
Satizabal, C. L., Beiser, A. S., Chouraki, V., Chêne, G., Dufouil, C., & Seshadri, S. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1504327 · Cited by 1,051
A Comparison of the Prevalence of Dementia in the United States in 2000 and 2012
Langa, K. M., Larson, E. B., Crimmins, E. M., Faul, J. D., Levine, D. A., Kabeto, M. U., & Weir, D. R. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.6807 · Cited by 910
Recent global trends in the prevalence and incidence of dementia, and survival with dementia
Prince, M., Ali, G.-C., Guerchet, M., Prina, A. M., Albanese, E., & Wu, Y.-T. (2016) · Alzheimer's Research & Therapy · doi:10.1186/s13195-016-0188-8 · Cited by 876
Rocca, W. A., Petersen, R. C., Knopman, D. S., Hebert, L. E., Evans, D. A., Hall, K. S., Gao, S., Unverzagt, F. W., Langa, K. M., Larson, E. B., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.11.002 · Cited by 498
Self-citationCognitive activity and incident AD in a population-based sample of older persons
Wilson, R. S., Bennett, D. A., Bienias, J. L., Aggarwal, N. T., Mendes de Leon, C. F., Morris, M. C., Schneider, J. A., & Evans, D. A. (2002) · Neurology · doi:10.1212/01.wnl.0000036905.59156.a1 · Cited by 456
Self-citation
Cited by
Sorted by citations
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
2023 Alzheimer's disease facts and figures
(2023) · Alzheimer's & Dementia · doi:10.1002/alz.13016 · Cited by 3,212
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
2024 Alzheimer's disease facts and figures
(2024) · Alzheimer's & Dementia · doi:10.1002/alz.13809 · Cited by 2,536
2019 Alzheimer’s disease facts and figures.
Alzheimer's Association (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.01.010 · Cited by 2,461
2020 Alzheimer's disease facts and figures
(2020) · Alzheimer's & Dementia · doi:10.1002/alz.12068 · Cited by 2,353
2022 Alzheimer's disease facts and figures
Anonymous (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12638 · Cited by 2,469
2021 Alzheimer's disease facts and figures
Anonymous (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12328 · Cited by 2,339
Rajan, K. B., Weuve, J., Barnes, L. L., McAninch, E. A., Wilson, R. S., & Evans, D. A. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12362 · Cited by 1,268
Self-citationMartin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z., Anderson, C. A. M., Arora, P. K., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001303 · Cited by 1,284
Alzheimer’s Disease: Epidemiology and Clinical Progression
Tahami Monfared, A. A., Byrnes, M. J., White, L. A., & Zhang, Q. (2022) · Neurology and Therapy · doi:10.1007/s40120-022-00338-8 · Cited by 629
2025 Alzheimer's disease facts and figures
(2025) · Alzheimer s & Dementia · doi:10.1002/alz.70235 · Cited by 642
Wolters, F. J., Chibnik, L. B., Waziry, R., Anderson, R., Berr, C., Beiser, A., Bis, J. C., Blacker, D., Bos, D., Brayne, C., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010022 · Cited by 489
Tauopathies: new perspectives and challenges
Zhang, Y., Wu, K.-M., Yang, L., Dong, Q., & Yu, J.-T. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00533-z · Cited by 323
Palaniappan, L. P., Allen, N. B., Almarzooq, Z., Anderson, C. A. M., Arora, P. K., Avery, C. L., Baker-Smith, C. M., Bansal, N., Currie, M. E., Earlie, R. S., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001412 · Cited by 343
Chen, L.-L., Fan, Y.-G., Zhao, L.-X., Zhang, Q., & Wang, Z.-Y. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106301 · Cited by 200
Diagnostic biomarkers of Alzheimer’s disease: A state-of-the-art review
Khoury, R., & Ghossoub, E. (2019) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2019.100005 · Cited by 200
Lanctôt, K. L., Hahn‐Pedersen, J. H., Eichinger, C. S., Freeman, C. S., Clark, A., Tarazona, L. R. S., & Cummings, J. L. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.61 · Cited by 163
Power, M. C., Bennett, E. E., Turner, R., Dowling, N. M., Ciarleglio, A., Glymour, M. M., & Gianattasio, K. Z. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.4471 · Cited by 160
Dilworth-Anderson, P., Moon, H., & Aranda, M. P. (2020) · The Gerontologist · doi:10.1093/geront/gnaa050 · Cited by 153
Wilkins, C. H., Windon, C., Dilworth‐Anderson, P., Romanoff, J., Gatsonis, C. G., Hanna, L., Apgar, C., Gareen, I. F., Hill, C. V., Hillner, B. E., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.3157 · Cited by 144
Alzheimer disease in African American individuals: increased incidence or not enough data?
Barnes, L. L. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-021-00589-3 · Cited by 142
Self-citationExploring Sphingolipid Implications in Neurodegeneration
Alessenko, A. V., & Albi, E. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00437 · Cited by 141
Culture, Ethnicity, and Level of Education in Alzheimer's Disease
Rosselli, M., Vélez-Uribe, I., Ahne, E., & Shihadeh, L. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01193-z · Cited by 154
Determining clinically meaningful decline in preclinical Alzheimer disease
Insel, P. S., Weiner, M., Mackin, R. S., Mormino, E., Lim, Y. Y., Stomrud, E., Palmqvist, S., Masters, C. L., Maruff, P. T., Hansson, O., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007831 · Cited by 128
Mukadam, N., Wolters, F. J., Walsh, S., Wallace, L., Brayne, C., Matthews, F. E., Sacuiu, S., Skoog, I., Seshadri, S., Beiser, A., et al. (2024) · The Lancet Public Health · doi:10.1016/s2468-2667(24)00120-8 · Cited by 136
Treatments for Alzheimer's disease emerge
Selkoe, D. J. (2021) · Science · doi:10.1126/science.abi6401 · Cited by 117
Exploring the efficacy of natural products in alleviating Alzheimer’s disease
Singh, A., Deshpande, P., & Gogia, N. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.253509 · Cited by 111
Gleason, C. E., Zuelsdorff, M., Gooding, D. C., Kind, A. J. H., Johnson, A. L., James, T. T., Lambrou, N. H., Wyman, M. F., Ketchum, F. B., Gee, A., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12511 · Cited by 104
Gleason, C. E., Norton, D., Zuelsdorff, M. L., Benton, S. F., Wyman, M. F., Nystrom, N. C., Lambrou, N. H., Salazar, H., Koscik, R. L., Jonaitis, E. M., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.07.015 · Cited by 98
Ethnic Differences in Dementia Risk: A Systematic Review and Meta-Analysis
Shiekh, S. I., Cadogan, S. L., Lin, L.-Y., Mathur, R., Smeeth, L. L., & Warren‐Gash, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201209 · Cited by 85
Relevance of biomarkers across different neurodegenerative diseases
Ehrenberg, A. J., Khatun, A., Coomans, E. M., Betts, M. J., Capraro, F., Thijssen, E. H., Senkevich, K. A., Bharucha, T., Jafarpour, M., Young, P. N. E., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00601-w · Cited by 81
Fu, C., Hao, W., Shrestha, N., Virani, S. S., Mishra, S. R., & Zhu, D. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101236 · Cited by 69
Pappagari, R. R., Cho, J., Moro-Velázquez, L., & Dehak, N. (2020) · Interspeech (USB) · doi:10.21437/interspeech.2020-2587 · Cited by 68
Modeste, E. S., Ping, L., Watson, C. M., Duong, D. M., Dammer, E. B., Johnson, E. C. B., Roberts, B. R., Lah, J. J., Levey, A. I., & Seyfried, N. T. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00638-z · Cited by 66
Pappagari, R. R., Cho, J., Joshi, S., Moro-Velázquez, L., Żelasko, P., Villalba, J., & Dehak, N. (2021) · Interspeech (USB) · doi:10.21437/interspeech.2021-1850 · Cited by 67
Advances on Therapeutic Strategies for Alzheimer’s Disease: From Medicinal Plant to Nanotechnology
Hassan, N. A., Alshamari, A. K., Hassan, A. A., Elharrif, M. G., Alhajri, A. M., Sattam, M., & Khattab, R. R. (2022) · Molecules · doi:10.3390/molecules27154839 · Cited by 68
Declining incidence of dementia: A national registry‐based study over 20 years
Taudorf, L., Nørgaard, A., Islamoska, S., Jørgensen, K., Laursen, T. M., & Waldemar, G. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.07.006 · Cited by 61
Aljeradat, B., Kumar, D., Abdulmuizz, S., Kundu, M., Almealawy, Y. F., Batarseh, D. R., Atallah, O., Ennabe, M., Alsarafandi, M., Alan, A., et al. (2024) · Pathophysiology · doi:10.3390/pathophysiology31020019 · Cited by 71
Myelin Pathology in Alzheimer's Disease: Potential Therapeutic Opportunities
Huang, Z., Jordan, J. D., & Zhang, Q. (2023) · Aging and Disease · doi:10.14336/ad.2023.0628 · Cited by 58
Racial/Ethnic Disparities in Alzheimer’s Disease Risk: Role of Exposure to Ambient Fine Particles
Younan, D., Wang, X., Gruenewald, T. L., Gatz, M., Serre, M. L., Vizuete, W., Braskie, M. N., Woods, N. F., He, K., García, L., et al. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab231 · Cited by 51
Ketogenic diet and cognition in neurological diseases: a systematic review
Pavon, S. E. D. C., Lázaro, E., Martínez, Ó., Amayra, I., Paz, J. F. L., Caballero, P., Al-Rashaida, M. A. H., Luna, P. M., García, M., Pérez, M., et al. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa113 · Cited by 49
Stem Cell Therapy for Alzheimer's Disease.
Han, F., Bi, J.-Z., Qiao, L.-Y., & Arancio, O. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-15-4370-8_4 · Cited by 19
Tom, S. E., Phadke, M. A., Hubbard, R. A., Crane, P. K., Stern, Y., & Larson, E. B. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.11094 · Cited by 47
Adherence to MIND Diet, Genetic Susceptibility, and Incident Dementia in Three US Cohorts
Vu, T. T., Beck, T. L., Bennett, D. A., Schneider, J. A., Hayden, K. M., Shadyab, A. H., Rajan, K. B., Morris, M. C., & Cornelis, M. C. (2022) · Nutrients · doi:10.3390/nu14132759 · Cited by 45
Self-citationTrends in postmortem neurodegenerative and cerebrovascular neuropathologies over 25 years
Grodstein, F., Leurgans, S. E., Capuano, A. W., Schneider, J. A., & Bennett, D. A. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2022.5416 · Cited by 41
Ding, D., Zhao, Q., Wu, W., Xiao, Z., Liang, X., Luo, J., & Hong, Z. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12159 · Cited by 41
Kim, J. H., Lee, H. S., Kim, Y. H., Kwon, M. J., Kim, J., Min, C., Yoo, D. M., & Choi, H. G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.815063 · Cited by 40
Maintenance of mitochondrial homeostasis for Alzheimer's disease: Strategies and challenges
Han, Y., Liu, D., Cheng, Y., Ji, Q., Liu, M., Zhang, B., & Zhou, S. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102734 · Cited by 41
2026 Alzheimer's disease facts and figures
(2026) · Alzheimer s & Dementia · doi:10.1002/alz.71345 · Cited by 69
Rotenberg, S., Maeir, A., & DAWSON, D. R. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2019.01393 · Cited by 40
Yang, J. J., Keohane, L. M., Pan, X.-F., Qu, R., Shu, X.-O., Lipworth, L., Braun, K., Steinwandel, M. D., Dai, Q., Shrubsole, M., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000200774 · Cited by 39
ApoE mimetic improves pathology and memory in a model of Alzheimer’s disease
Krishnamurthy, K., Cantillana, V., Wang, H., Sullivan, P. M., Kolls, B. J., Ge, X., Lin, Y., Mace, B., & Laskowitz, D. T. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146685 · Cited by 39
Gao, Y., Liu, J., Wang, J., Liu, Y., Zeng, L., Ge, W., & Ma, C. (2022) · Brain Pathology · doi:10.1111/bpa.13047 · Cited by 35
Zhang, B., Huang, X., Wang, X., Chen, X., Zheng, C., Shao, W., Wang, G., & Zhang, W. (2022) · Scientific Reports · doi:10.1038/s41598-022-17207-x · Cited by 39
Cognitive measures lacking in EHR prior to dementia or Alzheimer's disease diagnosis
Maserejian, N. N., Krzywy, H., Eaton, S., & Galvin, J. E. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12280 · Cited by 36
Infectious Disease Burden and the Risk of Alzheimer’s Disease: A Population-Based Study
Douros, A., Santella, C., Dell’Aniello, S., Azoulay, L., Renoux, C., Suissa, S., & Brassard, P. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-201534 · Cited by 37
Yoo, Y. K., Kim, G., Park, D., Kim, J., Kim, Y. S., Kim, H. Y., Yang, S. H., Lee, J. H., & Hwang, K. S. (2020) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2020.127710 · Cited by 37
Why Inclusion Matters for Alzheimer’s Disease Biomarker Discovery in Plasma
Khan, M. J., Desaire, H., López, O. L., Kamboh, M. I., & Robinson, R. A. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201318 · Cited by 35
Becerril, A. J., Pfoh, E. R., Hashmi, A. Z., Mourany, L., Gunzler, D. D., Berg, K. A., Krieger, N. I., Krishnan, K., Moore, S. E., Kahana, E. F., et al. (2023) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18322 · Cited by 35
Race, APOE ɛ4, and Long-Term Cognitive Trajectories in a Biracial Population Sample
Rajan, K. B., McAninch, E. A., Wilson, R. S., Weuve, J., Barnes, L. L., & Evans, D. A. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190538 · Cited by 39
Self-citationShaw, A. R., Perales-Puchalt, J., Moore, T., Weatherspoon, P., Robinson, M., Hill, C. V., & Vidoni, E. D. (2022) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2022.82 · Cited by 34
Ahmed, H. A., & Ishrat, T. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01964-9 · Cited by 33
Mutation spectrum of amyotrophic lateral sclerosis in Central South China
Liu, Z., Yuan, Y., Wang, M., Ni, J., Li, W., Huang, L., Hu, Y., Liu, P., Hou, X., Hou, X., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.06.008 · Cited by 33
Park, S.-Y., Setiawan, V. W., Crimmins, E. M., White, L. R., Wu, A. H., Cheng, I., Darst, B. F., Haiman, C. A., Wilkens, L. R., Le Marchand, L., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000208116 · Cited by 33
Swanson, L. M., Hood, M. M., Hall, M. H., Kravitz, H. M., Matthews, K. A., Joffe, H., Thurston, R. C., Butters, M. A., Ruppert, K. M., & Harlow, S. D. (2020) · SLEEP · doi:10.1093/sleep/zsaa182 · Cited by 31
Heparin-enriched plasma proteome is significantly altered in Alzheimer’s disease
Guo, Q. J., Ping, L., Dammer, E. B., Duong, D. M., Yin, L., Xu, K., Shantaraman, A., Fox, E. J., Golde, T. E., Johnson, E. C. B., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00757-1 · Cited by 38
Neuromodulation in the Treatment of Alzheimer’s Disease: Current and Emerging Approaches
Pople, C. B., Meng, Y., Li, D. Z., Bigioni, L., Davidson, B., Vecchio, L. M., Hamani, C., Rabin, J. S., & Lipsman, N. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200913 · Cited by 30
Wang, N., Cao, Y., Hao, S., Shao, Z., & Subbalakshmi, K. P. (2021) · Interspeech (USB) · doi:10.21437/interspeech.2021-2024 · Cited by 29
Brain Cytochrome P450: Navigating Neurological Health and Metabolic Regulation
Durairaj, P., & Liu, Z. L. (2025) · Journal of Xenobiotics · doi:10.3390/jox15020044 · Cited by 30
APOE4 , Blood Neurodegenerative Biomarkers, and Cognitive Decline in Community-Dwelling Older Adults
Ng, T. K. S., Beck, T. L., Boyle, P. A., Dhana, K., Desai, P., Evans, D. A., & Rajan, K. B. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.8903 · Cited by 29
Self-citationContador, I., Buch-Vicente, B., del Ser, T., Velasco, S. L., Villarejo‐Galende, A., Benito‐León, J., & Bermejo‐Pareja, F. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13144100 · Cited by 31
Ahmed, H. A., Ismael, S., Mirzahosseini, G., & Ishrat, T. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02350-9 · Cited by 27
ADAM10 plasma levels predict worsening in cognition of older adults: a 3-year follow-up study
Monteiro, M. P. A. O., Oliveira, D. S. M. S., Manzine, P. R., Nascimento, C. M. C., dos Santos‐Orlandi, A. A., Gomes, G. A. D. O., Orlandi, F. D. S., Zazzetta, M. S., Pott, H., & Cominetti, M. R. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00750-y · Cited by 26
Incidence of dementia in a Brazilian population: The Tremembé Epidemiologic Study
César‐Freitas, K. G., Suemoto, C. K., Power, M. C., Brucki, S. M. D., & Nitríni, R. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12423 · Cited by 32
Aging-simulation experience: impact on health professionals’ social representations
Pérot, J. G., Jarzebowski, W., Lafuente‐Lafuente, C., Crozet, C., & Belmin, J. (2020) · BMC Geriatrics · doi:10.1186/s12877-019-1409-3 · Cited by 26
O’Shea, D. M., Maynard, T. R., & Tremont, G. N. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac133 · Cited by 23
Lam, J., Hlávka, J. P., & Mattke, S. (2019) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2019.06.180328 · Cited by 24
Cheng, Y., Ahmed, A., Zamrini, E., Tsuang, D. W., Sheriff, H. M., & Zeng-Treitler, Q. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-191188 · Cited by 20
García, M. A., Warner, D. F., García, C., Downer, B. G., & Raji, M. A. (2021) · Innovation in Aging · doi:10.1093/geroni/igab039 · Cited by 23
Myoraku, A., Klein, G., Landau, S., Tosun, D., & Initiative, A. D. N. (2022) · European Journal of Hybrid Imaging · doi:10.1186/s41824-021-00123-0 · Cited by 26
Toward more diverse, inclusive, and equitable neuromodulation
Peebles, I. S., Phillips, T., & Hamilton, R. H. (2023) · Brain stimulation · doi:10.1016/j.brs.2023.04.013 · Cited by 22
Inequities in Filled Overactive Bladder Medication Prescriptions in the US
Luchristt, D., Bretschneider, C. E., Kenton, K. S., Simon, M. A., & Brown, O. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.15074 · Cited by 22
Clark, L. R., Norton, D., Berman, S. E., Johnson, S. C., Bendlin, B. B., Wieben, O. E., Turski, P. A., Carlsson, C. M., Asthana, S., Gleason, C. E., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190645 · Cited by 25
Neuropathology studies of dementia in US persons other than non-Hispanic whites
Nguyen, M.-L., Huie, E. Z., Whitmer, R. A., George, K. M., & Dugger, B. N. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3795 · Cited by 21
Mooko, T., Bala, A., Tripathy, S., Kumar, C. S. V., Mahadevappa, C. P., Chaudhary, S. K., & Matsabisa, M. G. (2021) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530321666210222124349 · Cited by 21
Wu, Q., & Gu, D. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_1121 · Cited by 23
Cheng, Y., ZAMRINI, E. Y., Faselis, C. J., Redd, D., Shao, Y., Morgan, C. J., Sheriff, H. M., Ahmed, A., Kokkinos, P. F., & Zeng‐Treitler, Q. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12998 · Cited by 20
Wang, Y., An, Y., Zhang, D., Yu, H., Zhang, X., Wang, Y., Tao, L., & Xiao, R. (2019) · PubMed · doi:10.1093/jnen/nlz002 · Cited by 19
Sattui, S. E., Rajan, M., Lieber, S. B., Lui, G. E., Sterling, M. R., Curtis, J. R., Mandl, L. A., & Navarro-Millán, I. Y. (2021) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.09.022 · Cited by 21
Self‐reported experiences of discrimination and incident dementia
Bancks, M. P., Byrd, G. S., Caban‐Holt, A., Fitzpatrick, A. L., Forrester, S., Hayden, K. M., Heckbert, S. R., Kershaw, K. N., Rapp, S. R., Sachs, B. C., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12947 · Cited by 19
Kishi, T., Sakuma, K., & Iwata, N. (2020) · Pharmacopsychiatry · doi:10.1055/a-1076-8228 · Cited by 20
Robotic assistance for people with dementia: a viable option for the future?
Gerłowska, J., Furtak-Niczyporuk, M., & Rejdak, K. (2020) · Expert Review of Medical Devices · doi:10.1080/17434440.2020.1770592 · Cited by 19
Power, M. C., Engelman, B., Wei, J., & Glymour, M. M. (2022) · Epidemiologic Reviews · doi:10.1093/epirev/mxac002 · Cited by 17
Wang, B., Shi, J.-Z., Zhai, W., Jiang, L., Ma, Y., Zhang, Z., Zhao, F., Wu, X., Wu, J. C. S., Wang, J., et al. (2024) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2024.136767 · Cited by 16
Elias, A., Cummins, T. L., Lamb, F., Tyrrell, R., Doré, V., Williams, R., Rosenfeld, J. V., Hopwood, M., Villemagne, V. L., & Rowe, C. C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190913 · Cited by 17
Bao, J., Liu, J., Li, Z., Zhang, Z., Su, X., Sun, J., Tu, J., Wang, J., Li, J., Song, Y., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.885598 · Cited by 19
Han, F., Liu, C., Huang, J., Chen, J., Wei, C., Geng, X., Liu, Y., Han, D., & Li, M. (2019) · Brain Science Advances · doi:10.1177/2096595819896178 · Cited by 16
Bermejo‐Pareja, F., Ciudad-Cabañas, M. J., Velasco, S. L., Tapias-Merino, E., Hernández‐Gallego, J., Hernández‐Cabria, M., Collado-Yurrita, L., & López‐Arrieta, J. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa045 · Cited by 18
Metadata
- Authors
- Rajan, K. B., Weuve, J., Barnes, L. L., Wilson, R. S., & Evans, D. A.
- Affiliations
- University of California, Davis (US)
- Boston University (US)
- Rush University Medical Center (US)
- Rush University (US)
- Corresponding author
- Rajan, Kumar B.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2018-09-06
- Volume
- 15
- Issue
- 1
- Pages
- 1-7
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- PMC
- PMC6531287
- OpenAlex
- W2891083286
- Cited by
- 245
- References
- 21
- Citations by year
- 2026: 18 · 2025: 22 · 2024: 47 · 2023: 38 · 2022: 36 · 2021: 37 · 2020: 29 · 2019: 17 · 2018: 1
- FWCI
- 16.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Alzheimer s & Dementia (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (RF1-AG057532, R01-AG051635, R01-AG11101)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- Alzheimer's disease, dementia
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Black or African American, Female, Humans, Male, Prospective Studies, Risk Factors, United States, Incidence, Prevalence, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
